These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 20581860

  • 21. Interaction of MLL amino terminal sequences with menin is required for transformation.
    Caslini C, Yang Z, El-Osta M, Milne TA, Slany RK, Hess JL.
    Cancer Res; 2007 Aug 01; 67(15):7275-83. PubMed ID: 17671196
    [Abstract] [Full Text] [Related]

  • 22. MOZ is essential for maintenance of hematopoietic stem cells.
    Katsumoto T, Aikawa Y, Iwama A, Ueda S, Ichikawa H, Ochiya T, Kitabayashi I.
    Genes Dev; 2006 May 15; 20(10):1321-30. PubMed ID: 16702405
    [Abstract] [Full Text] [Related]

  • 23. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.
    Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, Look AT.
    Blood; 2003 Jul 01; 102(1):262-8. PubMed ID: 12637319
    [Abstract] [Full Text] [Related]

  • 24. Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription.
    Chang PY, Hom RA, Musselman CA, Zhu L, Kuo A, Gozani O, Kutateladze TG, Cleary ML.
    J Mol Biol; 2010 Jul 09; 400(2):137-44. PubMed ID: 20452361
    [Abstract] [Full Text] [Related]

  • 25. Tandem PHD fingers of MORF/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin.
    Ali M, Yan K, Lalonde ME, Degerny C, Rothbart SB, Strahl BD, Côté J, Yang XJ, Kutateladze TG.
    J Mol Biol; 2012 Dec 14; 424(5):328-38. PubMed ID: 23063713
    [Abstract] [Full Text] [Related]

  • 26. Proton pump inhibitors selectively suppress MLL rearranged leukemia cells via disrupting MLL1-WDR5 protein-protein interaction.
    Chen WL, Li DD, Chen X, Wang YZ, Xu JJ, Jiang ZY, You QD, Guo XK.
    Eur J Med Chem; 2020 Feb 15; 188():112027. PubMed ID: 31923859
    [Abstract] [Full Text] [Related]

  • 27. NUP98-MLL fusion in human acute myeloblastic leukemia.
    Kaltenbach S, Soler G, Barin C, Gervais C, Bernard OA, Penard-Lacronique V, Romana SP.
    Blood; 2010 Sep 30; 116(13):2332-5. PubMed ID: 20558618
    [Abstract] [Full Text] [Related]

  • 28. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Li Z, Chen P, Su R, Hu C, Li Y, Elkahloun AG, Zuo Z, Gurbuxani S, Arnovitz S, Weng H, Wang Y, Li S, Huang H, Neilly MB, Wang GG, Jiang X, Liu PP, Jin J, Chen J.
    Cancer Res; 2016 Feb 01; 76(3):619-29. PubMed ID: 26747896
    [Abstract] [Full Text] [Related]

  • 29. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
    Jin S, Zhao H, Yi Y, Nakata Y, Kalota A, Gewirtz AM.
    J Clin Invest; 2010 Feb 01; 120(2):593-606. PubMed ID: 20093773
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Histone Acetyltransferase Activity of MOF Is Required for MLL-AF9 Leukemogenesis.
    Valerio DG, Xu H, Chen CW, Hoshii T, Eisold ME, Delaney C, Cusan M, Deshpande AJ, Huang CH, Lujambio A, Zheng YG, Zuber J, Pandita TK, Lowe SW, Armstrong SA.
    Cancer Res; 2017 Apr 01; 77(7):1753-1762. PubMed ID: 28202522
    [Abstract] [Full Text] [Related]

  • 33. SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
    Ropa J, Saha N, Hu H, Peterson LF, Talpaz M, Muntean AG.
    Haematologica; 2020 Sep 01; 105(9):2273-2285. PubMed ID: 33054052
    [Abstract] [Full Text] [Related]

  • 34. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
    Takahashi S, Kanai A, Okuda H, Miyamoto R, Komata Y, Kawamura T, Matsui H, Inaba T, Takaori-Kondo A, Yokoyama A.
    Elife; 2021 Aug 25; 10():. PubMed ID: 34431785
    [Abstract] [Full Text] [Related]

  • 35. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
    Yokoyama A.
    Cancer Sci; 2021 Oct 25; 112(10):3935-3944. PubMed ID: 34251718
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.